Oura Agrees to Acquire Counsel Health in $625M Cash Deal

The medical conversation can begin with information collected long before anyone books an appointment. Oura wants more of those conversations to happen inside its own app, where the health patterns recorded by a ring can accompany a request for care. Its planned acquisition of Counsel Health puts a physician-backed service beside that daily stream of information.

On November 10, 2026, the companies announced a definitive agreement for Oura to acquire Counsel Health for $625M in cash, subject to purchase-price adjustments. Closing is expected before the end of 2026 under customary conditions. The transaction builds on an existing partnership and would connect Oura's consumer health platform more closely with Counsel's medical AI and physicians, while preserving Counsel's access to enterprise customers outside the ring business.

The agreement expands a care relationship already underway

This is an acquisition of an existing partner, with a service relationship to carry forward. Oura's acquisition announcement describes a partnership dating to May 2026; its public app-integration article followed in June. Oura members can move from health information in the app into a Counsel conversation, rather than starting the search for help in another service.

The division of work is consequential. Oura Ring collects physiological signals and the app translates those measurements into health insights. Counsel supplies medical AI under physician supervision and access to doctors who can diagnose, treat, order labs and prescribe when appropriate. Members must give permission before Counsel physicians can see their Oura data and previous conversations. That consent belongs inside the explanation of how the combined experience works.

Tom Hale, Oura's CEO, describes the acquisition as a way to extend personalized care. The joint transaction announcement outlines intended work across preventive, acute, specialty and chronic care. Those ambitions describe a development agenda; a purchase agreement supplies no timetable for every proposed capability. The companies have disclosed the cash price and expected closing window, while leaving detailed integration economics and future service pricing open.

Counsel brings a medical group alongside its software

Dr. Muthu Alagappan started Counsel in 2023 after a career combining AI research and clinical practice. His official biography describes work as Notable Health's CMO and as an attending physician at Massachusetts General Hospital and UCSF. Counsel's current leadership page also identifies Robert Christ as CTO, Dr. Rishi Khakhkhar as CMO and Dr. Aaron Neinstein as chief growth officer. The organization spans engineering, clinical care and commercial distribution because the product requires each to function.

Counsel's financing history shows how quickly that model attracted institutional backing. Its October 2025 announcement disclosed a $25M Series A led by a16z and GV, following an $11M Seed led by a16z in October 2024. Alagappan's account of the Series A also names Asymmetric, Floodgate and Pear VC as participants. Those are earlier financings, separate from the consideration Oura has agreed to pay sellers.

The useful asset for Oura is the combination of software and the people authorized to deliver care through it. A physician-supervised service has to decide when a conversation needs a doctor, preserve clinical context and support the actions that follow. Owning that capability would give Oura more influence over the experience after a member asks for help. It also brings the practical work of care delivery closer to the company that introduced the member to the service.

The enterprise customer keeps a separate seat at the table

Counsel has made an unusually useful commitment for understanding the commercial shape of this deal. In his statement on the acquisition, Alagappan says existing and new enterprise partners will continue to be served, and their populations will not need to own or purchase Oura Rings. He also says members can keep using Counsel's consumer application for now, with further information to come.

For a health plan or employer, that preserves a purchasing conversation centered on access to care. The prospective owner gains a route to people outside its existing membership, while the enterprise customer can continue considering Counsel on the service's own terms. Ring data may add context for some patients; distribution through a payer or employer reaches a different relationship with the buyer.

Keeping both channels useful will require attention to their different obligations. A consumer may arrive with a personal health question after checking the Oura App. An enterprise partner must decide how the service fits the population it serves and the other benefits or care pathways it already supports. The ring-independent commitment leaves room for those decisions, giving Counsel's enterprise organization a purpose that continues beyond supporting sales of Oura hardware.

The wearable purchase now leads into a service relationship

Oura began in Oulu, Finland, in 2013, according to its company history. Its evolution from sleep and recovery tracking into a wider health platform gives this acquisition a recognizable direction: more of the work surrounding a measurement becomes part of the customer relationship. Counsel would add an organization that can respond when a member seeks medical help.

The broader healthcare AI investment picture includes distinct pieces of that work. DevCuration's coverage of Zus Health's connected patient-data financing and Alterra Labs' medical AI evaluation financing provides adjacent context. Data access, evaluation and care delivery each introduce their own operating responsibilities; buying one capability still leaves the task of connecting it coherently to the others.

Oura and Counsel are proposing a closer connection between the health record people generate in daily life and the conversation in which a clinician helps them interpret it. As closing approaches, the enterprise promise keeps the circle wider than ring owners. Counsel's doctors will still have patients arriving through employers and health plans, carrying questions that the newly combined business will need to answer even when there is no Oura device supplying the first clue.